[Tissue plasminogen activator in urine of patients with prostatic carcinoma and benign prostatic hyperplasia].
In the 20 patients with prostatic carcinoma (PC) and the 18 with benign prostatic hyperplasia (BPH) the level of tissue type plasminogen activator (t-PA:Ag) was examined. As a compared group consisted of 24 healthy volunteers. In the urine of examined patients with PC and BPH and control the t-PA:Ag was absent or present only in trace amounts. We concluded that the t-PA:Ag in the urine of patients with PC can not be as a marker in the diagnosis of prostatic diseases especially in the prostatic carcinoma.
Zietek
Z
Z
Katedry i Kliniki Urologii, Bydgoszczy.
Iwan-Zietek
I
I
Kotschy
M
M
Wolski
Z
Z
Kulwas
A
A
Białkowska
A
A
D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000652:urine*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011470:Prostatic Hyperplasia / Q000652:urine*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000652:urine*; D012680:Sensitivity and Specificity; D010959:Tissue Plasminogen Activator / Q000652:urine*
D014408:Biomarkers, Tumor; D010959:Tissue Plasminogen Activator